Approximate deal size €500m
Wallaby Medical of Los Angeles (USA) and Shanghai (China) acquired phenox of Bochum (Germany), Galway (Ireland), Birmingham (UK), Milan (Italy), and Los Angeles (USA). Both businesses design and manufacture high quality (catheter) medical devices for the treatment of different types of brain-stroke. The acquisition provided the platform for the combined business to become a significant player, if not the leader, in neurovascular technologies and solutions to customers and patients globally, including in the USA, Europe, Japan, China and various other markets.
The acquisition combined two highly complementary products, their pipelines of R&D, sales networks, and local market knowledge around the world.
The integration objectives were to leverage phenox's European market position and Wallaby's China position. Products were complimentary, allowing the marketing of a matrix of solutions for different customer needs.
Intista was engaged to integrate the IT of the businesses across all the locations. Significant effort was put into creating an IT environment that fostered simple and effective collaboration between the disparate locations.
Challenges that were overcome included
- phenox operated IT in a very decentralized model, whereas Wallaby used a centralized model
- Moving 6 phenox IT environments to a single environment, providing ease of communication for the business
- A lack of corporate-wide IT inventory
- Many disparate email systems and domains
- Employee communication and troubleshooting
- Coordinating corporate initiatives with local independent IT contractors in six countries
- Migrating large amounts of locally held data to the cloud while sustaining business-as-usual